Boxer Capital as of Dec. 31, 2015
Portfolio Holdings for Boxer Capital
Boxer Capital holds 15 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 55.2 | $64M | 2.0M | 31.60 | |
| Aquinox Pharmaceuticals | 8.7 | $10M | 809k | 12.48 | |
| Blueprint Medicines (BPMC) | 7.1 | $8.3M | 314k | 26.34 | |
| Seattle Genetics | 6.2 | $7.2M | 160k | 44.88 | |
| Kura Oncology (KURA) | 4.8 | $5.5M | 655k | 8.40 | |
| Vitae Pharmaceuticals | 3.9 | $4.5M | 250k | 18.10 | |
| Aradigm | 3.8 | $4.4M | 1.1M | 3.97 | |
| Zogenix | 2.9 | $3.3M | 225k | 14.74 | |
| Celladon | 1.8 | $2.1M | 1.4M | 1.47 | |
| Akari Therapeutics | 1.8 | $2.0M | 140k | 14.50 | |
| Sophiris Bio | 1.5 | $1.8M | 1.0M | 1.78 | |
| Nabriva Therapeutics | 1.5 | $1.7M | 177k | 9.55 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.5 | $528k | 155k | 3.41 | |
| Aldeyra Therapeutics (ALDX) | 0.4 | $428k | 63k | 6.78 | |
| Essa Pharma | 0.1 | $119k | 28k | 4.23 |
